Jan Chu

1.9k total citations · 1 hit paper
5 papers, 208 citations indexed

About

Jan Chu is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Jan Chu has authored 5 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Jan Chu's work include CAR-T cell therapy research (4 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). Jan Chu is often cited by papers focused on CAR-T cell therapy research (4 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). Jan Chu collaborates with scholars based in United Kingdom. Jan Chu's co-authors include Robert Chiesa, David O’Connor, Soragia Athina Gkazi, Kimberly Gilmour, Christos Georgiadis, Stuart Adams, Rebecca Thomas, Ajay Vora, Giorgio Ottaviano and Roland Preece and has published in prestigious journals such as New England Journal of Medicine, Blood and Blood Advances.

In The Last Decade

Jan Chu

3 papers receiving 203 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

2023 174 citations Robert Chiesa, Christos Georgiadis et al. New England Journal of Medicine profile →

Peers

Jan Chu

ONCOL

MB

GENET

BE

IMMUN

Farhatullah Syed United Kingdom

Wengang Ge China

January Salas-McKee United States

Neil Humphryes-Kirilov United Kingdom

Leili Moezzi Australia

Nicole Verdun United States

Gul Ahsan United Kingdom

Miroslaw Kozlowski United States

Sara Silbert United States

Farhatullah Syed United Kingdom

Jan Chu

127 ×0.8

ONCOL

108 ×0.9

MB

61 ×0.8

GENET

32 ×0.8

BE

36 ×1.0

IMMUN

Citations per year, relative to Jan Chu Jan Chu (= 1×) peers Farhatullah Syed

Countries citing papers authored by Jan Chu

Since Specialization

Citations

This map shows the geographic impact of Jan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Chu more than expected).

Fields of papers citing papers by Jan Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Chu. The network helps show where Jan Chu may publish in the future.

Co-authorship network of co-authors of Jan Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Chu. A scholar is included among the top collaborators of Jan Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Chu. Jan Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chiesa, Robert, Christos Georgiadis, Hani Rashed, et al.. (2025). Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia. New England Journal of Medicine. 394(2). 152–165.

2.

Chiesa, Robert, Christos Georgiadis, Farhatullah Syed, et al.. (2023). Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia. New England Journal of Medicine. 389(10). 899–910. 174 indexed citations breakdown →

3.

Mullanfiroze, Khushnuma, Arina Lazareva, Jan Chu, et al.. (2022). CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy. Blood Advances. 6(16). 4715–4718. 30 indexed citations

4.

Williams, Lindsey, Jan Chu, Alasdair Bamford, et al.. (2022). SARS-CoV-2–specific T-cell responses to recurrent COVID-19 pneumonitis in a patient with post-CART B-cell aplasia. Blood Advances. 6(5). 1577–1579.

5.

Ottaviano, Giorgio, Christos Georgiadis, Farhatullah Syed, et al.. (2021). TT52CAR19: Phase 1 Trial of CRISPR/Cas9 Edited Allogeneic CAR19 T Cells for Paediatric Relapsed/Refractory B-ALL. Blood. 138(Supplement 1). 4838–4838. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact